Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines
Clinical trial NCT05146999 · COMPLETED
Trial details
- NCT number
- NCT05146999
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-09
- Primary completion
- 2022-10-28
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.